Quest Diagnostics
DGX
#1135
Rank
$16.01 B
Marketcap
$143.91
Share price
2.09%
Change (1 day)
-0.08%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Operating Margin for Quest Diagnostics (DGX)

Operating Margin as of July 2024 (TTM): 12.04%

According to Quest Diagnostics 's latest financial reports and stock price the company's current Operating Margin is 12.04%. At the end of 2023 the company had an Operating Margin of 12.21%.

Operating Margin history for Quest Diagnostics from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202312.21%-2.26%
202212.50%-48.13%
202124.09%20.68%
202019.96%43.35%
201913.93%13.27%
201812.30%-11.64%
201713.92%-7.57%
201615.05%2.27%
201514.72%32.98%
201411.07%-40.26%
201318.53%28.08%
201214.47%25.95%
201111.49%-29.03%
201016.18%-1.74%
200916.47%17.18%
200814.06%3.29%
200713.61%-17.44%
200616.48%-5.32%
200517.41%6.94%
200416.28%4.54%
200315.57%17.95%
200213.20%61.49%
20018.18%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
4.67%-61.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-16.10%-233.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-31.26%-359.63%๐Ÿ‡บ๐Ÿ‡ธ USA
73.09% 507.06%๐Ÿ‡บ๐Ÿ‡ธ USA
18.52% 53.80%๐Ÿ‡บ๐Ÿ‡ธ USA
21.86% 81.56%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.